I knew someone more sophisticated in statistics would respond. We agree it would be appropriate for POC. I am probably overly extrapolating from the pivotal trial emphasis on ITT analysis in my comment about publication-worthiness, I'm happy to hear there could be some flexibility there.
Market Data 
Markets 
AI
